METTL3 and neoplasm: In parallel, propionate alters histone acetylation and affects methyltransferase-like 3 (METTL3)–mediated m6A deposition, promoting tumor survival and therapy resistance through the regulation of lipid metabolism and ferroptosis tolerance (99).